Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is a paper indexed in PICO Portal from OpenAlex.
How many citations does Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies have?
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has 77 citations in the OpenAlex counts PICO Portal stores.
When was Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies published?
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has 2021 year in the PICO Portal index.
What is the open-access status of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has hybrid oa status in the PICO Portal index.
What is the DOI of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?
The DOI for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.
What is the PMID of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?
The PMID for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.
What is the OpenAlex record for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?
The OpenAlex for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.